Track the 티앤알바이오팹 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 티앤알바이오팹 has recorded 107 reports. Market capitalisation: €110.1bn. The latest transaction was reported on 30 June 2026 (Other). Among the most active insiders: 윤원수. All data is accessible without an account.
107
Insider Decl.
0
Thresholds
€280,357
19 ops.
Buy Volume
·
1 ops.
Sell Volume
30Σ signal
Buys €280,357· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 25,148 of 26,270 companies
14.8
score / 100
Value
12
Quality
18
FCF yld-10%
Earn yld-37%
EV/EBITDA·
ROE-146%
Gross mgn26%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
티앤알바이오팹 is a company specializing in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative technologies in the biopharmaceutical field.
